Concepedia

Junti Lu

JL

Statistics

Publications

5

Citations

144

H-Index

5

Active since

2014

Affiliations

Hubei University of Medicine(Current)

Taihe Hospital

Wuhan University

Renmin Hospital of Wuhan University

Junti Lu is an author at Hubei University of Medicine specializing in tumor biology, cancer therapeutics, and cell engineering.

ORCID

Top concepts

Publications per year

2014–2022

5

Publications

5

TRAIL-engineered bone marrow-derived mesenchymal stem cells: TRAIL expression and cytotoxic effects on C6 glioma cells.

Xiangjun Tang, Junti Lu, Hanjun Tu et al. · PubMed · 2014 · 37 citations

Protective effect of microRNA-138 against cerebral ischemia/reperfusion injury in rats

Xiangjun Tang, Minghuan Yang, Gang Cao et al. · Experimental and Therapeutic Medicine · 2016 · 34 citations · Full text

Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells

Xiangjun Tang, Kuan-Ming Huang, Hui Gui et al. · International Journal of Nanomedicine · 2016 · 32 citations · Full text

, , +17

Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients

Xiangjun Tang, Pengfei Xu, Bin Wang et al. · Frontiers in Oncology · 2019 · 21 citations · Full text

Synthetic mRNA-based gene therapy for glioblastoma: TRAIL-mRNA synergistically enhances PTEN-mRNA-based therapy

Xiangjun Tang, Hao Peng, Pengfei Xu et al. · Molecular Therapy — Oncolytics · 2022 · 20 citations · Full text

1–5 of 5